FCE-26600

N/A

Report date: 2023/05/22 10:18:16

Base Information

Drug NameFCE-26600
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibiotics > Carbapenems antibiotics
Mechanisms of ActionTopoisomerase (DNA) II alpha inhibitorsCell wall inhibitors
TargetsTopoisomerase (DNA) II alpha
Therapy Area/IndicationsBacterial Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPharmacia Corporation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPharmacia Corporation
Active IndicationsN/A
Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A
Related LinksN/A